After COVID-19 brought the world to a screeching halt in 2020, specialist healthcare communications firm M Booth Health worked with pharma and advocacy organizations to guide the conversation about safety, vaccines and mitigation.
Led by CEO Tim Bird, the agency helped reframe the credibility of the Institute for Health Metrics and Evaluation (IHME), a University of Washington research center that provides COVID-19 case and mortality projections, and increase awareness of its global network. The firm has also led communications for Gilead Science, manufacturer of COVID-treating drug remdesivir. Social marketing health campaigns including Penn’s State “Mask Up or Pack Up” directly led to increased mask-wearing and a decrease in COVID-cases.
Remaining steadfast in his leadership throughout the pandemic, Bird has also presented himself as an advocate for LGBTQ+ health rights. As a member of the gay community and a father of two, Bird has championed and led campaigns around issues such as HIV prevention in the Black and Hispanic communities, as well as access to HIV treating medication PREP.
While M Booth Health ended 2020 with a 12% drop in revenue according to PRWeek, 2021 is headed in a different direction, with Bird confident that continued COVID-related comms will turn the tide.